1. Home
  2. AXGN vs THQ Comparison

AXGN vs THQ Comparison

Compare AXGN & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • THQ
  • Stock Information
  • Founded
  • AXGN N/A
  • THQ 2014
  • Country
  • AXGN United States
  • THQ United States
  • Employees
  • AXGN N/A
  • THQ N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • THQ Finance Companies
  • Sector
  • AXGN Health Care
  • THQ Finance
  • Exchange
  • AXGN Nasdaq
  • THQ Nasdaq
  • Market Cap
  • AXGN 804.8M
  • THQ 714.6M
  • IPO Year
  • AXGN N/A
  • THQ N/A
  • Fundamental
  • Price
  • AXGN $23.44
  • THQ $17.40
  • Analyst Decision
  • AXGN Strong Buy
  • THQ
  • Analyst Count
  • AXGN 7
  • THQ 0
  • Target Price
  • AXGN $27.71
  • THQ N/A
  • AVG Volume (30 Days)
  • AXGN 889.9K
  • THQ 158.9K
  • Earning Date
  • AXGN 10-29-2025
  • THQ 01-01-0001
  • Dividend Yield
  • AXGN N/A
  • THQ 7.53%
  • EPS Growth
  • AXGN N/A
  • THQ N/A
  • EPS
  • AXGN N/A
  • THQ N/A
  • Revenue
  • AXGN $214,709,000.00
  • THQ N/A
  • Revenue This Year
  • AXGN $21.57
  • THQ N/A
  • Revenue Next Year
  • AXGN $15.79
  • THQ N/A
  • P/E Ratio
  • AXGN N/A
  • THQ N/A
  • Revenue Growth
  • AXGN 18.72
  • THQ N/A
  • 52 Week Low
  • AXGN $9.22
  • THQ $15.29
  • 52 Week High
  • AXGN $24.25
  • THQ $20.38
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 72.25
  • THQ 37.11
  • Support Level
  • AXGN $23.19
  • THQ $17.65
  • Resistance Level
  • AXGN $24.25
  • THQ $18.25
  • Average True Range (ATR)
  • AXGN 1.15
  • THQ 0.21
  • MACD
  • AXGN 0.47
  • THQ -0.11
  • Stochastic Oscillator
  • AXGN 86.87
  • THQ 11.88

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.

Share on Social Networks: